Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 26,621 |
|
|||||
| News | - | ||||||
| Day High | 35.34 | Low High |
|||||
| Day Low | 34.58 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Collegium Pharmaceutical Inc | COLL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.28 | 0.81% | 35.05 | 10:21:54 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 34.65 | 34.58 | 35.34 | 34.77 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 474 | 26,621 | $ 34.82 | $ 926,904 | - | 20.83 - 40.95 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:21:54 | 100 | $ 35.05 | USD |
Collegium Pharmaceutical Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.12B | 31.96M | - | 566.77M | 48.16M | 1.51 | 23.24 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Collegium Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COLL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 36.51 | 36.51 | 34.58 | 35.34 | 306,185 | -1.46 | -4.00% |
| 1 Month | 39.56 | 40.95 | 34.58 | 38.18 | 335,418 | -4.51 | -11.40% |
| 3 Months | 33.76 | 40.95 | 31.34 | 36.70 | 416,066 | 1.29 | 3.82% |
| 6 Months | 21.63 | 40.95 | 20.95 | 32.18 | 413,592 | 13.42 | 62.04% |
| 1 Year | 23.13 | 40.95 | 20.83 | 28.14 | 360,063 | 11.92 | 51.53% |
| 3 Years | 23.34 | 40.95 | 14.04 | 23.58 | 332,564 | 11.71 | 50.17% |
| 5 Years | 13.56 | 40.95 | 10.01 | 21.56 | 369,399 | 21.49 | 158.48% |
Collegium Pharmaceutical Description
| Collegium Pharmaceutical Inc is a specialty pharmaceutical company. It is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release & immediate-release formulations of tapentadol. |
